isoxazoles has been researched along with Coxsackie Virus Infections in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galabov, AS; Vassileva-Pencheva, R | 1 |
| Artemenko, AG; Khristova, T; Kuz'min, VE; Makarov, VA; Muratov, EN; Riabova, OB; Schmidtke, M; Varlamova, EV; Wutzler, P | 1 |
| Galabov, AS; Nikolova, I | 1 |
| See, DM; Tilles, JG | 2 |
| Fohlman, J; Friman, G; Ilbäck, NG; Pauksen, K | 1 |
| Fohlman, J; Friman, G; Ilbäck, NG; Pauksen, K; Stålhandske, T; Wesslén, L | 1 |
| Eggertsen, G; Ehrnst, A; Fohlman, J; Friman, G; Hyypiä, T; Ilbäck, NG; Pauksen, K | 1 |
| Grumbach, IM; Heim, A; Müller, G; Pfetzing, U | 1 |
| Galabov, AS; Nikolaeva, L | 1 |
| Diana, GD; Dutko, FJ; McKinlay, MA; Otto, MJ; Rogge, MC; Woods, MG | 1 |
11 other study(ies) available for isoxazoles and Coxsackie Virus Infections
| Article | Year |
|---|---|
Effectiveness of the Consecutive Alternating Administration Course of a Triple Antiviral Combination in Coxsackievirus B3 Infections in Mice.
Topics: Animals; Animals, Newborn; Antiviral Agents; Apomorphine; Coxsackievirus Infections; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Isoxazoles; Mice; Mice, Inbred ICR | 2016 |
QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
Topics: Antiviral Agents; Coxsackievirus Infections; Drug Design; Enterovirus B, Human; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Quantitative Structure-Activity Relationship | 2011 |
Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice.
Topics: Animals; Animals, Newborn; Antiviral Agents; Brain; Cell Line; Coxsackievirus Infections; Drug Resistance, Viral; Enterovirus B, Human; Isoxazoles; Mice; Mutation; Phenotype; Temperature; Viral Plaque Assay; Virulence | 2003 |
WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.
Topics: Animals; Antiviral Agents; Autoantibodies; Base Sequence; Coxsackievirus Infections; Diabetes Mellitus, Experimental; Enterovirus B, Human; Glucose Tolerance Test; Insulin; Islets of Langerhans; Isoxazoles; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Molecular Sequence Data; Pancreas; RNA, Viral; Time Factors | 1993 |
Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.
Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Dosage Forms; Enterovirus B, Human; Female; Isoxazoles; Mice; Mice, Inbred BALB C; Myocarditis; Pharmaceutical Vehicles | 1993 |
Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Coxsackievirus Infections; Enterovirus B, Human; Female; Hydroxyquinolines; Interferon-gamma; Isoxazoles; Mice; Mice, Inbred BALB C; Myocarditis; Tumor Necrosis Factor-alpha | 1993 |
Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Blotting, Northern; Complement C3; Complement Factor B; Complement System Proteins; Coxsackievirus Infections; Enterovirus; Enterovirus B, Human; Isoxazoles; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred CBA; Myocarditis; Neutralization Tests; RNA, Messenger; Survival Analysis | 1996 |
Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.
Topics: Animals; Antiviral Agents; Carrier State; Cells, Cultured; Chlorocebus aethiops; Coxsackievirus Infections; Dose-Response Relationship, Drug; Enterovirus B, Human; Fibroblasts; Heart; Humans; In Situ Hybridization; Isoxazoles; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Vero Cells; Viral Plaque Assay; Virus Replication | 1998 |
Antiviral effect of the combination of enviroxime and disoxaril on coxsackievirus B1 infection.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cell Line; Coxsackievirus Infections; Drug Synergism; Enterovirus B, Human; Humans; Isoxazoles; Mice; Mice, Inbred ICR; Oximes; Sulfonamides; Virus Replication | 2000 |
Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.
Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Enterovirus; Isoxazoles; Male; Mice; Myocarditis; Myocardium; Organ Size | 1992 |
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
Topics: Animals; Animals, Suckling; Antiviral Agents; Coxsackievirus Infections; Culture Media; Echovirus Infections; Female; Isoxazoles; Mice; Mice, Inbred ICR; Oxazoles; Picornaviridae; Rhinovirus; Viral Plaque Assay; Virus Replication | 1989 |